Rosendahl has an extensive experience in pharmaceutical development and commercialization from the pharmaceutical industry. She served in various management and senior positions in global and US organisations. Most recently as Global Product VP AstraZeneca and Head of Global Launch Excellence at Roche. Various Board of Director responsibilities.
Bo Söderpalm, M.D., Ph.D., is Professor and Chief physician at the Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry at the Sahlgrenska Academy, University of Gothenburg. He is the Co-Founder of Sobrera Pharma. Söderpalm is an experienced senior researcher and clinician since 30 years and has performed several clinical studies in the area of alcohol abuse.
Andrea de Bejczy
Head of R&D
Andrea de Bejczy, M.D., Ph.D., at the Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry at the Sahlgrenska Academy, University of Gothenburg is the Co-Founder of Sobrera Pharma. She is an experienced researcher and clinician and has performed several clinical studies in the area of alcohol abuse.
Elisabeth Bolling Sternevald
Senior Project Director
Elisabeth Bolling Sternevald PhD, has more than 30 years’ extensive experience within the pharmaceutical industry. In Astra Zeneca, she held several global senior leadership positions in the areas of drug portfolio managment/development and disease area strategy development. At Antaros Medical she served as COO where she together with the company’s CEO and the scientific experts, turned the newly established company to a highly value-adding and innovative player in the MRI/PET imaging business.
Clinical Project Director
Rebeckha Magnusson has worked in the Clinical Development area for more than 15 years. She has an extensive and broad experience from various positions, mainly within Clinical and Project Management, in both big Pharmaceutical and small Biotech companies such as AstraZeneca and IRLAB. Most recent position as Head of Clinical Operations at Antaros Medical. Rebeckha is certified in Lean Six sigma.
Ulf Bredberg has more than 25 years experience in the Pharmacutical Industry, primarily from AstraZeneca and Vertex Pharmaceuticals. He has held several senior leadership positions in preclinical and clinical development with emphasis on pharmacokinetics (DMPK), quantitative pharmacology and biopharmaceutics.
Eva Bredberg has more than 25 years of experience in the pharmaceutical Industry primarily from AstraZeneca and Vertex Pharmaceuticals. She has had several senior leadership roles within Clinical development, with particularly focus on Early Development and Clinical Pharmacology.
Eva Byröd has more than 35 years experience in the Pharmaceutical Industry, primarily from AstraZeneca. She has held several senior leadership positions in the area of Pharmaceutical Research and Development with focus on drug delivery and formulation development, but also project management. She has experience from all phases of drug development, from preclinical to clinical phase and commercialisation.